Innovent Biologics Inc. (1801:HK) (IVBXF) PT Raised to HK$1,101 at Credit Suisse

April 5, 2021 2:04 AM EDT
Get Alerts 1801:HK Hot Sheet
Price: $0.00 --0%

Rating Summary:
    0 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 18 | Down: 20 | New: 68
Trade Now! 
Join SI Premium – FREE
Credit Suisse analyst Yang Huang raised the price target on Innovent Biologics Inc. (1801:HK) (OTC: IVBXF) to HK$1,101.00 (from HK$120.00) while maintaining a Outperform rating.

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst PT Change, Intl Ratings